COMMUNIQUÉS West-GlobeNewswire

Adaptimmune Data to be Presented at American Society of Hematology (ASH) Annual Meeting Confirm NY-ESO SPEAR T-cell Efficacy in Multiple Myeloma Pilot Study

05/12/2017 - 23:00

PHILADELPHIA, Pa. and OXFORD, UK, Dec. 05, 2017 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq: ADAP ), a leader in T-cell therapy to treat cancer, will have updated data from its completed pilot study 1 of NY [...]

MacroGenics Announces Closing of MGA012 Global Collaboration and License Agreement with Incyte

05/12/2017 - 22:30

ROCKVILLE, MD, Dec. 05, 2017 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX ), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for [...]

Editas Medicine, Inc., Announces Offering of Common Stock

05/12/2017 - 22:17

CAMBRIDGE, Mass., Dec. 05, 2017 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ: EDIT ), a leading genome editing company, today announced that it intends to offer and sell $50,000,000 of shares of its common stock in [...]

Portola Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

05/12/2017 - 22:14

SOUTH SAN FRANCISCO, Calif., Dec. 05, 2017 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc. ® (NASDAQ: PTLA ) announced today that on November 27, 2017, the Compensation Committee of the Board of Directors approved, [...]

HealthEquity Reports Third Quarter Ended October 31, 2017 Financial Results

05/12/2017 - 22:05

Highlights of the third quarter include: Revenue of $56.8 million, an increase of 31% compared to Q3 FY17. Net income of $10.5 million, an increase of 74% compared to Q3 FY17. Net income per diluted share of $0.17 [...]

GW Pharmaceuticals Announces Proposed Public Offering of ADSs

05/12/2017 - 22:01

LONDON, Dec. 05, 2017 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq: GWPH ) ("GW" or the “Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its [...]

Advanced Accelerator Applications Board of Directors Recommends $3.9 Billion All Cash Tender Offer by Novartis

05/12/2017 - 22:00

SAINT-GENIS-POUILLY, France, Dec. 05, 2017 (GLOBE NEWSWIRE) -- Advanced Accelerator Applications S.A. (NASDAQ: AAAP ) (AAA or the Company), a leader in nuclear medicine theragnostics, today announced that its Board of [...]

Dr. Bill Williams Guest Appearance at “CEO MONEY” Radio Show

05/12/2017 - 21:41

BERKELEY, Calif. and VANCOUVER, British Columbia, Dec. 05, 2017 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. ("BriaCell" or the "Company") (TSX-V: BCT ) (OTCQB:BCTXF), an immuno-oncology focused biotechnology company [...]

UConn Professor Honored for Prosthodontic Humanitarian Efforts

05/12/2017 - 19:05

Chicago, Dec. 05, 2017 (GLOBE NEWSWIRE) -- John R. Agar, DDS, MA, FACP , was honored with the Distinguished Service Award by the American College of Prosthodontists (ACP) at the Annual Awards & President’s Dinner [...]

Orphazyme A/S: Stabilisation measures taken

05/12/2017 - 19:00

Company announcement No. 15/2017 Orphazyme A/S Ole Maaløes Vej 3 DK-2200 Copenhagen N www.orphazyme.com Company Registration No. 32266355 5 December 2017 NOT FOR RELEASE OR DISTRIBUTION OR PUBLICATION IN WHOLE OR IN [...]

Cleartronic’s (CLRI) ReadyOp Software Platform Now Being Used by LA Metro

05/12/2017 - 19:00

BOCA RATON, Fla., Dec. 05, 2017 (GLOBE NEWSWIRE) -- Cleartronic, Inc. (OTCPINK:CLRI) announced that its wholly-owned subsidiary, ReadyOp Communications, Inc., has signed LA Metro, the largest mass transit authority in [...]

Ozempic® (semaglutide) approved in the US

05/12/2017 - 18:49

Bagsværd, Denmark, 5 December 2017 - Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved Ozempic ® (semaglutide injection). Ozempic ® is indicated as an adjunct to diet and exercise [...]

Essilor: Disclosure of Share Capital and Voting Rights Outstanding as of November 30, 2017

05/12/2017 - 18:01

Disclosure of Share Capital and Voting Rights Outstanding as of November 30, 2017 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité [...]

Essilor : Nombre total de droits de vote et d'actions composant le capital social au 30 novembre 2017

05/12/2017 - 18:01

Nombre total de droits de vote et d'actions composant le capital social au 30 novembre 2017 (Article L.233-8 II du Code de Commerce et les articles 221-1 et 223-16 du Règlement Général de l'AMF) Charenton-le-Pont, [...]

In new survey of patients, Inspire examines clinical trials, genetic testing

05/12/2017 - 18:00

ARLINGTON, Va., Dec. 05, 2017 (GLOBE NEWSWIRE) -- In a new survey by Inspire, three of 10 respondents say they have talked to their doctors about enrolling in clinical trials, and about 14% actually participated in a [...]

AFA Invites Teens To Enter Its 2018 “Teens For Alzheimer’s Awareness” College Scholarship Essay Contest

05/12/2017 - 17:46

NEW YORK, Dec. 05, 2017 (GLOBE NEWSWIRE) -- The Alzheimer’s Foundation of America (AFA) is inviting high school seniors to take part in its 2018 “Teens for Alzheimer’s Awareness” College Scholarship Essay Contest. The [...]

RadNet, Inc. to Present at 10th Annual LD Micro Main Event Conference in Los Angeles on December 7th

05/12/2017 - 17:41

LOS ANGELES, Dec. 05, 2017 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT ), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of owned and operated outpatient [...]

Kalytera Confirms No Material Change in Operations

05/12/2017 - 17:10

SAN FRANCISCO and TEL AVIV, Israel, Dec. 05, 2017 (GLOBE NEWSWIRE) -- At the request of IIROC, Kalytera Therapeutics, Inc. (TSX-V: KALY ) (OTCQB:KALTF) (the " Company " or " Kalytera ") wishes to confirm that the [...]

ABILITY Network Helps Skilled Nursing Providers Streamline the Triple Check Process

05/12/2017 - 16:18

MINNEAPOLIS, Dec. 05, 2017 (GLOBE NEWSWIRE) -- ABILITY Network, a leading information technology company, today announced that it has added a powerful capability to its ABILITY | UBWATCH application to help streamline [...]